ログイン

Cancer

Cancer
54問 • 2年前
  • Two Clean Queens
  • 通報

    問題一覧

  • 1

    Any swelling caused by inflammation

    Tumor

  • 2

    New, abnormal growth, following uncontrolled proliferation serving no physiological purpose

    Neoplasm

  • 3

    Slow growth, well-defined capsule, not invasive, well differentiated, no metastasis, low mitotic index

    Benign Tumor

  • 4

    Rapid growth, not encapsulated, invasive, poor differentiation (anaplasia), high mitotic index, can spread distally (metastasis)

    Malignant Tumor

  • 5

    Abnormal, uncontrolled, spread

    Cancer

  • 6

    -Constantly replace selves -Regenerate using adult stem cells -Stem cells are multi/pluripotent

    Normal cells

  • 7

    -Heterogeneous (diverse character/content) -Cancer stem cells

    Cancer Cells

  • 8

    Pre-invasive cancer; atypical cells. “In its original place”, cancer cells have not spread beyond where they were first formed, and have not penetrated the basement membrane (no local invasion)

    Carcinoma in situ

  • 9

    Tumors and other abnormal growths (morbid growth)

    -oma

  • 10

    Cancer from epithelial cells

    Carcinoma

  • 11

    Cancer from mesenchymal cells

    -sarcoma

  • 12

    Cancer from ductal or glandular tissue

    Adenocarcinoma

  • 13

    Cancer from blood forming cells

    Leukemia

  • 14

    Cancer from lymphatic cells

    Lymphoma

  • 15

    Cancer in precursor cells (blasts); common in children

    -blastoma

  • 16

    Mutated or over-expressed proto-oncogenes, which are independent of normal regulatory mechanisms. May amplify, making numerous copies of mutated genes that are important in prognosis and therapy.

    Oncogenes

  • 17

    Genes that inhibit or decelerate proliferation-> suppress oncogenes (decrease cell growth, mutation, replication)-> end result of gene changes = loss of caretaker gene function (TP53)

    Tumor suppressor gene role in cancer suppression

  • 18

    -Cancer cells use inflammation to their benefit to support growth and progression -Have ability to produce chemotactic signals -> attract macrophages-> produce mediators -> decrease inflammation and increase proliferation and angiogenesis, recruit macrophages, decrease cytotoxic response to not kill cancer cells -T-regulatory cells change -> no cell destruction + produce cytokines -> proliferation/spread

    Inflammation role in cancer progression

  • 19

    Muscle wasting, loss of lean body mass with or without adipose tissue, multi-organ syndrome, systemic inflammation, negative protein energy balance -Changes in mitochondrial Ca+ signaling, loss of myofibrils -Increased apoptosis and decrease regeneration -White adiopose tissue breakdown -> conversion to brown adipose tissue with increased thermogenesis (IL-6) -Changes in appetite hormones —>(Orexin < Anorexin levels)

    Cachexia

  • 20

    -(Rare) triggered by immune system response to neoplasm -Involves non-metastatic systematic effects that accompany malignant disease -Collection of symptoms produced by tumor occurring remotely from the tumor origin -Can effect neuromuscular, CV, cutaneous, hematologic, GI, renal, miscellaneous Examples - -SIADH <- intracranial neoplams -> release ADH -Venous thrombosis <- pancreatic carcinoma -> tumor products activate clotting

    Paraneoplastic Syndrome

  • 21

    It measures liver and germ cells

    Alpha Fetoprotein

  • 22

    It measures prostate cells

    PSA

  • 23

    It measures germ cell choriocarcinoma (for numerous cancers - colon, lung, and breast)

    Carcinoembryonic antigen

  • 24

    It measures urine marker for multiple myeloma

    Bence Jones Protein

  • 25

    It measures marker for small cell lung cancer and neuroblastoma

    Neuron-specific enolase

  • 26

    -The higher number the worse the prognosis - (T) indicates tumor spread - (N) indicates node involvement - (M) indicates presence of distal metastasis

    Process of staging cancers

  • 27

    Most common cancers - leukemia and brain tumor, solid tumors

    Cancer in Children

  • 28

    Lymphoma most common. Leukemia, thyroid carcinoma, brain tumors, and germ cell tumors are also common

    Cancer in Adolescents

  • 29

    Incidence increases with age, changes in immune system, immunocompetence, longer time exposed to potential gene mutations. More likely to develop solid organ tumor.

    Cancer in Elderly

  • 30

    Diagnosis during active growth periods, and approximately 85% are cured

    Cancer in Adolescents and Children

  • 31

    -Risk factors: smoking , COPD -Manifestations: non-productive cough, hemoptysis, PNA, atelectasis -Site of Metastasis: hila and project into bronchi

    Squamos cell carcinoma (lung)

  • 32

    -Risk factors: women, Asians, non-smokers -Manifestations: asymptomatic, and usually found on unrelated CXR -Site of metastasis: periphery of lung parenchyma

    Adenocarcinoma (lung)

  • 33

    -Risk factors: men > 60 yo, Asians -Manifestations: non-productive cough, hemoptysis, chest pain, PNA, SOB, orthopnea -Site of metastasis: central and distal trachea

    Large cell carcinoma (lung)

  • 34

    -Risk factors: smoking (strong relation) -Manifestations: Hyponatremia, Cushing’s, hypocalcemia, gyneomastia, carcinoid syndrome, Lambert-Eaton myasthenic syndrome -Pathophysiology: neuroendrocrine tumors derived from neuro-secretory granules in tracheobronchial trees -Site of metastasis: central portion of the lung

    Small cell carcinoma (lung)

  • 35

    -Risk factors: smoking, ETOH, low intake of fruit/vegetables, low zinc intake, hot food beverages -Manifestations: Chest pain and dysphagia -Pathophysiology: r/t chronic inflammation and metaplastic changes -Site of metastasis: upper portion of esophagus

    Squamous cell carcinoma (esophagus)

  • 36

    -Risk factors: Barrett’s esophagus, GERD, obesity, smoking, sliding hiatal hernia -Site of metastasis: lower esophagus

    Adenocarcinoma (esophagus)

  • 37

    -Risk factors: familial adenomatous polyposis, age 50+, black, family Hx, smoking, obesity, inactivity, high fat and low fiber diet, IBD, genetics, DMII -Etiology: arise from polyps in intestinal mucosal epithelium -Manifestations: if large enough-> bowel obstruction; pain abdominal mass, anemia, occult blood, distension -Pathophysiology: polyps with frequency in size

    Colon Cancer

  • 38

    -Risk factors: increase with age, ETOH, family Hx, non-O blood type, DMII, chronic pancreatitis, smoking, BRCA-2, Lynchburg and FAMMM Syndromes, K-ras (proto-oncogene) -Etiology: tumors arise from exocrine (more likely) and endocrine cells -Manifestations: obstruction of portal vein and common bile duct -> jaundice, dull black stool, protein and fat malabsorption, lethargy; weight loss, N/V, new onset DM, pruritis, light-colored or floating stools, dark urine, flank or back pain, abdominal pain, DVT

    Pancreatic cancer

  • 39

    -Risk factors: Family Hx, ovarian, breast, or uterine cancers, IVF, post-menopausal, infertility, early menarche, late menopause, endometriosis, BRCA1>BRCA2, Turners Syndrome -Etiology: unclear -Manifestations: vague, non-specific; Early -> decreased appetite, abdominal and pelvic pain, Late -> pain, ascities, dyspepsia, vomiting, change in bowel habits

    Ovarian cancer

  • 40

    -Risk factors: white > black (higher mortality), early menarche, late menopause, nulliparity, family Hx, personal Hx of breast or ovarian cancers, tamoxifen use, failure to ovulate, obesity, DMII, HTN, gallbladder disease -Etiology: prolonged estrogen exposure in absence of progesterone -Manifestations: post-menopausal bleeding, pain, weight loss (late sign), Metastasis -> lungs! -Pathophysiology: arises from glandular epithelial of the uterine lining (75% are Adenocarcinoma)

    Endometrial cancer

  • 41

    -Risk factors: early age at onset of sexual activity, multiple high risk partners, high risk HPV (strains 16 and 18), smoking, oral contraceptives, immunodeficiency -Etiology: HPV strains 16, 18 are higher risk; 6 & 11 are lower risk -Manifestations: no symptoms in early stage; large absent, may have post-coital vaginal bleeding, malodorous discharge, and abdominal uterine bleeding (late sign) -Pathophysiology: pre-cancerous dysplasia and cervical carcinoma in situ

    Cervical cancer

  • 42

    -Risk factors: early age (15-35 yo), white, Hx of undescended testicle, family Hx, HIV, Klinefelter Syndrome, genetics -Etiology: unknown -Manifestations: painless right testicular mass and heavinesses, dull ache in lower abdomen and lumbar, gynecomastia, CNS symptoms; Metastasis -> lung and brain! -Pathophysiology: malignant neoplasm of the testicle

    Testicular cancer

  • 43

    -Risk factors: age 50+, black, vasectomy, family Hx, high fat diet, smoking, obesity, ingestion of proinflammatory oils (corn and safflower oils), other tumor suppressors-> Genes BRCA2>BRCA1 -Etiology: unknown -Manifestations: not present until advanced stage - slow urinary stream, incomplete bladder emptying, low back pain, nocturia, dysuria, erectile dysfunction, increased alkaline phosphatase, rectal obstruction, pelvic pain; Metastasis-> vertebrae and pelvic bones! -Pathophysiology: imbalance of estrogen-androgen in epithelial cells

    Prostate cancer

  • 44

    -Risk factors: metabolic syndromes - dyslipidemia, insulin resistance, obesity, genetics, thyroid syndromes -Defining characteristics: irregular ovulation, increased androgen levels, polycystic ovaries -Manifestations: anovulation, hyperandrogenism, insulin dysfunction, bleeding/amenorrhea, hirsutism, acne, acanthosis nigricans, infertility -Pathophysiology: altered FSH results in failure of follicules to fully mature and alters ovulation

    Polycystic Ovarian Syndrome

  • 45

    -Risk factors: common during reproductive years in women -Defining characteristics: benign unilateral cysts

    Ovarian cysts

  • 46

    Follicle stimulated but does not mature, rupture, or regress. Symptoms- bloating, breast tenderness and swelling, heavy/irregular menses. Most are fluid-filled and reabsorpted with next “normal” hormone cycle

    Follicular cysts

  • 47

    Formed by granulosa cells “left behind” after ovulation (more prone to rupture) Symptoms-dull, unilateral pelvic pain, amenorrhea-> heavy irregular bleeding. Most regress spontaneously in non-pregnant women

    Corpus Luteum Cysts

  • 48

    Triggers a tissue-remodeling matrix -> makes new blood vessels for cancer cells

    Metalloproteinases

  • 49

    4 known genetic mechanisms of oncogenes

    1) point mutations 2) translocation with excess production of proliferation factor 3) translocation with production of proteins with growth-promoting properties 4) gene amplification

  • 50

    Sensitive but not specific

    AFP

  • 51

    Specific but not sensitive

    PSA

  • 52

    Metastasis-> vertebrae and pelvic bones!

    Prostate Cancer

  • 53

    Metastasis -> lung and brain!

    Testicular Cancer

  • 54

    Metastisis -> lungs!

    Endometrial Cancer

  • Patho Renal

    Patho Renal

    Two Clean Queens · 100問 · 2年前

    Patho Renal

    Patho Renal

    100問 • 2年前
    Two Clean Queens

    Pathophysiology

    Pathophysiology

    Two Clean Queens · 100問 · 2年前

    Pathophysiology

    Pathophysiology

    100問 • 2年前
    Two Clean Queens

    Patho Immunology

    Patho Immunology

    Two Clean Queens · 34問 · 2年前

    Patho Immunology

    Patho Immunology

    34問 • 2年前
    Two Clean Queens

    Patho Hematology

    Patho Hematology

    Two Clean Queens · 100問 · 2年前

    Patho Hematology

    Patho Hematology

    100問 • 2年前
    Two Clean Queens

    Patho Hematology 2

    Patho Hematology 2

    Two Clean Queens · 76問 · 2年前

    Patho Hematology 2

    Patho Hematology 2

    76問 • 2年前
    Two Clean Queens

    Patho Respiratory

    Patho Respiratory

    Two Clean Queens · 100問 · 2年前

    Patho Respiratory

    Patho Respiratory

    100問 • 2年前
    Two Clean Queens

    Patho Respiratory 2

    Patho Respiratory 2

    Two Clean Queens · 54問 · 2年前

    Patho Respiratory 2

    Patho Respiratory 2

    54問 • 2年前
    Two Clean Queens

    Patho Cardiovascular

    Patho Cardiovascular

    Two Clean Queens · 100問 · 2年前

    Patho Cardiovascular

    Patho Cardiovascular

    100問 • 2年前
    Two Clean Queens

    Patho Cardiovascular 2

    Patho Cardiovascular 2

    Two Clean Queens · 56問 · 2年前

    Patho Cardiovascular 2

    Patho Cardiovascular 2

    56問 • 2年前
    Two Clean Queens

    Patho MSK

    Patho MSK

    Two Clean Queens · 52問 · 2年前

    Patho MSK

    Patho MSK

    52問 • 2年前
    Two Clean Queens

    Patho Acid Base

    Patho Acid Base

    Two Clean Queens · 35問 · 2年前

    Patho Acid Base

    Patho Acid Base

    35問 • 2年前
    Two Clean Queens

    Renal 2

    Renal 2

    Two Clean Queens · 10問 · 2年前

    Renal 2

    Renal 2

    10問 • 2年前
    Two Clean Queens

    Fluid Balance

    Fluid Balance

    Two Clean Queens · 43問 · 2年前

    Fluid Balance

    Fluid Balance

    43問 • 2年前
    Two Clean Queens

    Patho Endocrine

    Patho Endocrine

    Two Clean Queens · 100問 · 2年前

    Patho Endocrine

    Patho Endocrine

    100問 • 2年前
    Two Clean Queens

    Patho Endocrine 2

    Patho Endocrine 2

    Two Clean Queens · 42問 · 2年前

    Patho Endocrine 2

    Patho Endocrine 2

    42問 • 2年前
    Two Clean Queens

    Infections

    Infections

    Two Clean Queens · 58問 · 2年前

    Infections

    Infections

    58問 • 2年前
    Two Clean Queens

    Patho Shock

    Patho Shock

    Two Clean Queens · 31問 · 2年前

    Patho Shock

    Patho Shock

    31問 • 2年前
    Two Clean Queens

    GI

    GI

    Two Clean Queens · 100問 · 2年前

    GI

    GI

    100問 • 2年前
    Two Clean Queens

    GI 2

    GI 2

    Two Clean Queens · 18問 · 2年前

    GI 2

    GI 2

    18問 • 2年前
    Two Clean Queens

    Neuro

    Neuro

    Two Clean Queens · 94問 · 2年前

    Neuro

    Neuro

    94問 • 2年前
    Two Clean Queens

    Psychopathology

    Psychopathology

    Two Clean Queens · 20問 · 2年前

    Psychopathology

    Psychopathology

    20問 • 2年前
    Two Clean Queens

    Bone Pharm

    Bone Pharm

    Two Clean Queens · 77問 · 2年前

    Bone Pharm

    Bone Pharm

    77問 • 2年前
    Two Clean Queens

    Urology Pharm

    Urology Pharm

    Two Clean Queens · 68問 · 2年前

    Urology Pharm

    Urology Pharm

    68問 • 2年前
    Two Clean Queens

    Lifestyle Considerations Outline_Pharm

    Lifestyle Considerations Outline_Pharm

    Two Clean Queens · 97問 · 2年前

    Lifestyle Considerations Outline_Pharm

    Lifestyle Considerations Outline_Pharm

    97問 • 2年前
    Two Clean Queens

    Prescribing Basics Outline_Pharm

    Prescribing Basics Outline_Pharm

    Two Clean Queens · 23問 · 2年前

    Prescribing Basics Outline_Pharm

    Prescribing Basics Outline_Pharm

    23問 • 2年前
    Two Clean Queens

    Pharmacokinetics_Pharm

    Pharmacokinetics_Pharm

    Two Clean Queens · 31問 · 2年前

    Pharmacokinetics_Pharm

    Pharmacokinetics_Pharm

    31問 • 2年前
    Two Clean Queens

    Diabetes Pharm

    Diabetes Pharm

    Two Clean Queens · 100問 · 2年前

    Diabetes Pharm

    Diabetes Pharm

    100問 • 2年前
    Two Clean Queens

    Diabetes Pharm 2

    Diabetes Pharm 2

    Two Clean Queens · 41問 · 2年前

    Diabetes Pharm 2

    Diabetes Pharm 2

    41問 • 2年前
    Two Clean Queens

    Neuroendocrine Obesity Pharm

    Neuroendocrine Obesity Pharm

    Two Clean Queens · 100問 · 2年前

    Neuroendocrine Obesity Pharm

    Neuroendocrine Obesity Pharm

    100問 • 2年前
    Two Clean Queens

    Neuroendocrine Obesity Pharm 2

    Neuroendocrine Obesity Pharm 2

    Two Clean Queens · 43問 · 2年前

    Neuroendocrine Obesity Pharm 2

    Neuroendocrine Obesity Pharm 2

    43問 • 2年前
    Two Clean Queens

    Dermatology Pharm

    Dermatology Pharm

    Two Clean Queens · 106問 · 1年前

    Dermatology Pharm

    Dermatology Pharm

    106問 • 1年前
    Two Clean Queens

    Dermatology Pharm 2

    Dermatology Pharm 2

    Two Clean Queens · 24問 · 1年前

    Dermatology Pharm 2

    Dermatology Pharm 2

    24問 • 1年前
    Two Clean Queens

    Cardiac/Renal Pharm 1

    Cardiac/Renal Pharm 1

    Two Clean Queens · 100問 · 1年前

    Cardiac/Renal Pharm 1

    Cardiac/Renal Pharm 1

    100問 • 1年前
    Two Clean Queens

    Cardiac/Renal Pharm 2

    Cardiac/Renal Pharm 2

    Two Clean Queens · 100問 · 1年前

    Cardiac/Renal Pharm 2

    Cardiac/Renal Pharm 2

    100問 • 1年前
    Two Clean Queens

    Cardiac/Renal Pharm 3

    Cardiac/Renal Pharm 3

    Two Clean Queens · 86問 · 1年前

    Cardiac/Renal Pharm 3

    Cardiac/Renal Pharm 3

    86問 • 1年前
    Two Clean Queens

    Anticoagulants Pharm

    Anticoagulants Pharm

    Two Clean Queens · 46問 · 1年前

    Anticoagulants Pharm

    Anticoagulants Pharm

    46問 • 1年前
    Two Clean Queens

    Herbals

    Herbals

    Two Clean Queens · 48問 · 1年前

    Herbals

    Herbals

    48問 • 1年前
    Two Clean Queens

    N5220 Exam Pearls

    N5220 Exam Pearls

    Two Clean Queens · 100問 · 1年前

    N5220 Exam Pearls

    N5220 Exam Pearls

    100問 • 1年前
    Two Clean Queens

    DRIQ

    DRIQ

    Two Clean Queens · 67問 · 1年前

    DRIQ

    DRIQ

    67問 • 1年前
    Two Clean Queens

    Clinical Pearls Test 2

    Clinical Pearls Test 2

    Two Clean Queens · 76問 · 1年前

    Clinical Pearls Test 2

    Clinical Pearls Test 2

    76問 • 1年前
    Two Clean Queens

    Test 2 Seidel's Part I

    Test 2 Seidel's Part I

    Two Clean Queens · 94問 · 1年前

    Test 2 Seidel's Part I

    Test 2 Seidel's Part I

    94問 • 1年前
    Two Clean Queens

    Test 2 Seidel's Part II

    Test 2 Seidel's Part II

    Two Clean Queens · 98問 · 1年前

    Test 2 Seidel's Part II

    Test 2 Seidel's Part II

    98問 • 1年前
    Two Clean Queens

    NURS 5112 Exam Review Part 1

    NURS 5112 Exam Review Part 1

    Two Clean Queens · 66問 · 1年前

    NURS 5112 Exam Review Part 1

    NURS 5112 Exam Review Part 1

    66問 • 1年前
    Two Clean Queens

    NURS 5140 Exam 1 Review Part 1

    NURS 5140 Exam 1 Review Part 1

    Two Clean Queens · 100問 · 1年前

    NURS 5140 Exam 1 Review Part 1

    NURS 5140 Exam 1 Review Part 1

    100問 • 1年前
    Two Clean Queens

    NURS 5140 Exam 1 Review Application Part 1

    NURS 5140 Exam 1 Review Application Part 1

    Two Clean Queens · 100問 · 1年前

    NURS 5140 Exam 1 Review Application Part 1

    NURS 5140 Exam 1 Review Application Part 1

    100問 • 1年前
    Two Clean Queens

    NURS 5410 Exam 1 ApplicationPart 2

    NURS 5410 Exam 1 ApplicationPart 2

    Two Clean Queens · 50問 · 1年前

    NURS 5410 Exam 1 ApplicationPart 2

    NURS 5410 Exam 1 ApplicationPart 2

    50問 • 1年前
    Two Clean Queens

    Exam 2 NURS 5140

    Exam 2 NURS 5140

    Two Clean Queens · 8問 · 1年前

    Exam 2 NURS 5140

    Exam 2 NURS 5140

    8問 • 1年前
    Two Clean Queens

    NURS 5112 Exam 2 ChatGPT

    NURS 5112 Exam 2 ChatGPT

    Two Clean Queens · 90問 · 1年前

    NURS 5112 Exam 2 ChatGPT

    NURS 5112 Exam 2 ChatGPT

    90問 • 1年前
    Two Clean Queens

    Exam 3 NURS 5410 Anxiety

    Exam 3 NURS 5410 Anxiety

    Two Clean Queens · 66問 · 1年前

    Exam 3 NURS 5410 Anxiety

    Exam 3 NURS 5410 Anxiety

    66問 • 1年前
    Two Clean Queens

    Exam 3 NURS 5410 Pain

    Exam 3 NURS 5410 Pain

    Two Clean Queens · 44問 · 1年前

    Exam 3 NURS 5410 Pain

    Exam 3 NURS 5410 Pain

    44問 • 1年前
    Two Clean Queens

    Exam 3 NURS 5410 Sleep

    Exam 3 NURS 5410 Sleep

    Two Clean Queens · 72問 · 1年前

    Exam 3 NURS 5410 Sleep

    Exam 3 NURS 5410 Sleep

    72問 • 1年前
    Two Clean Queens

    NURS 5410 Exam 3 Quizzes

    NURS 5410 Exam 3 Quizzes

    Two Clean Queens · 25問 · 1年前

    NURS 5410 Exam 3 Quizzes

    NURS 5410 Exam 3 Quizzes

    25問 • 1年前
    Two Clean Queens

    Psychopharm Exam 1

    Psychopharm Exam 1

    Two Clean Queens · 71問 · 1年前

    Psychopharm Exam 1

    Psychopharm Exam 1

    71問 • 1年前
    Two Clean Queens

    Gero Psych Exam 1

    Gero Psych Exam 1

    Two Clean Queens · 62問 · 1年前

    Gero Psych Exam 1

    Gero Psych Exam 1

    62問 • 1年前
    Two Clean Queens

    Psychopharmacology Exam 2 (part 1)

    Psychopharmacology Exam 2 (part 1)

    Two Clean Queens · 19問 · 1年前

    Psychopharmacology Exam 2 (part 1)

    Psychopharmacology Exam 2 (part 1)

    19問 • 1年前
    Two Clean Queens

    Peds Psych Exam 2 (part 1)

    Peds Psych Exam 2 (part 1)

    Two Clean Queens · 19問 · 1年前

    Peds Psych Exam 2 (part 1)

    Peds Psych Exam 2 (part 1)

    19問 • 1年前
    Two Clean Queens

    Peds Psych Exam 2 (part 2)

    Peds Psych Exam 2 (part 2)

    Two Clean Queens · 50問 · 1年前

    Peds Psych Exam 2 (part 2)

    Peds Psych Exam 2 (part 2)

    50問 • 1年前
    Two Clean Queens

    Peds Psych Exam 2 (part 3)

    Peds Psych Exam 2 (part 3)

    Two Clean Queens · 67問 · 1年前

    Peds Psych Exam 2 (part 3)

    Peds Psych Exam 2 (part 3)

    67問 • 1年前
    Two Clean Queens

    Peds Psych Exam 2 (part 4)

    Peds Psych Exam 2 (part 4)

    Two Clean Queens · 20問 · 1年前

    Peds Psych Exam 2 (part 4)

    Peds Psych Exam 2 (part 4)

    20問 • 1年前
    Two Clean Queens

    Psychopharmacology Exam 2 (part 2)

    Psychopharmacology Exam 2 (part 2)

    Two Clean Queens · 80問 · 1年前

    Psychopharmacology Exam 2 (part 2)

    Psychopharmacology Exam 2 (part 2)

    80問 • 1年前
    Two Clean Queens

    Psychopharmacology Exam 2 (part 3)

    Psychopharmacology Exam 2 (part 3)

    Two Clean Queens · 46問 · 1年前

    Psychopharmacology Exam 2 (part 3)

    Psychopharmacology Exam 2 (part 3)

    46問 • 1年前
    Two Clean Queens

    Psychopharmacology Exam 2 (part 4)

    Psychopharmacology Exam 2 (part 4)

    Two Clean Queens · 22問 · 1年前

    Psychopharmacology Exam 2 (part 4)

    Psychopharmacology Exam 2 (part 4)

    22問 • 1年前
    Two Clean Queens

    Psychopharm Depressive Disorders

    Psychopharm Depressive Disorders

    Two Clean Queens · 86問 · 11ヶ月前

    Psychopharm Depressive Disorders

    Psychopharm Depressive Disorders

    86問 • 11ヶ月前
    Two Clean Queens

    Psychopharm Bipolar Disorder

    Psychopharm Bipolar Disorder

    Two Clean Queens · 58問 · 11ヶ月前

    Psychopharm Bipolar Disorder

    Psychopharm Bipolar Disorder

    58問 • 11ヶ月前
    Two Clean Queens

    Psychopharm Anxiety Disorders

    Psychopharm Anxiety Disorders

    Two Clean Queens · 32問 · 11ヶ月前

    Psychopharm Anxiety Disorders

    Psychopharm Anxiety Disorders

    32問 • 11ヶ月前
    Two Clean Queens

    Child Psych Anxiety

    Child Psych Anxiety

    Two Clean Queens · 56問 · 11ヶ月前

    Child Psych Anxiety

    Child Psych Anxiety

    56問 • 11ヶ月前
    Two Clean Queens

    Child Psych OCD/Gen Dysph

    Child Psych OCD/Gen Dysph

    Two Clean Queens · 34問 · 11ヶ月前

    Child Psych OCD/Gen Dysph

    Child Psych OCD/Gen Dysph

    34問 • 11ヶ月前
    Two Clean Queens

    Child Psych Eating Disorders 1

    Child Psych Eating Disorders 1

    Two Clean Queens · 49問 · 11ヶ月前

    Child Psych Eating Disorders 1

    Child Psych Eating Disorders 1

    49問 • 11ヶ月前
    Two Clean Queens

    Child Psych Eating Disorders 2

    Child Psych Eating Disorders 2

    Two Clean Queens · 14問 · 11ヶ月前

    Child Psych Eating Disorders 2

    Child Psych Eating Disorders 2

    14問 • 11ヶ月前
    Two Clean Queens

    Gero Mood Disorders

    Gero Mood Disorders

    Two Clean Queens · 19問 · 11ヶ月前

    Gero Mood Disorders

    Gero Mood Disorders

    19問 • 11ヶ月前
    Two Clean Queens

    Gero Anxiety Disorders

    Gero Anxiety Disorders

    Two Clean Queens · 13問 · 11ヶ月前

    Gero Anxiety Disorders

    Gero Anxiety Disorders

    13問 • 11ヶ月前
    Two Clean Queens

    Gero OCD & PTSD

    Gero OCD & PTSD

    Two Clean Queens · 15問 · 11ヶ月前

    Gero OCD & PTSD

    Gero OCD & PTSD

    15問 • 11ヶ月前
    Two Clean Queens

    Psychopharm Sleep

    Psychopharm Sleep

    Two Clean Queens · 34問 · 10ヶ月前

    Psychopharm Sleep

    Psychopharm Sleep

    34問 • 10ヶ月前
    Two Clean Queens

    Psychopharm ADHD

    Psychopharm ADHD

    Two Clean Queens · 20問 · 10ヶ月前

    Psychopharm ADHD

    Psychopharm ADHD

    20問 • 10ヶ月前
    Two Clean Queens

    Psychopharm Eating Disorders

    Psychopharm Eating Disorders

    Two Clean Queens · 6問 · 10ヶ月前

    Psychopharm Eating Disorders

    Psychopharm Eating Disorders

    6問 • 10ヶ月前
    Two Clean Queens

    Psychopharm Reward and Pleasure

    Psychopharm Reward and Pleasure

    Two Clean Queens · 32問 · 10ヶ月前

    Psychopharm Reward and Pleasure

    Psychopharm Reward and Pleasure

    32問 • 10ヶ月前
    Two Clean Queens

    Psychopharm Impulsivity/Compulsvity/Addiction

    Psychopharm Impulsivity/Compulsvity/Addiction

    Two Clean Queens · 7問 · 10ヶ月前

    Psychopharm Impulsivity/Compulsvity/Addiction

    Psychopharm Impulsivity/Compulsvity/Addiction

    7問 • 10ヶ月前
    Two Clean Queens

    Gero Exam 4 Review

    Gero Exam 4 Review

    Two Clean Queens · 81問 · 10ヶ月前

    Gero Exam 4 Review

    Gero Exam 4 Review

    81問 • 10ヶ月前
    Two Clean Queens

    Child Psych Sleep/Wake Disorders

    Child Psych Sleep/Wake Disorders

    Two Clean Queens · 58問 · 10ヶ月前

    Child Psych Sleep/Wake Disorders

    Child Psych Sleep/Wake Disorders

    58問 • 10ヶ月前
    Two Clean Queens

    Child Psych ODD/CD/SUD

    Child Psych ODD/CD/SUD

    Two Clean Queens · 49問 · 10ヶ月前

    Child Psych ODD/CD/SUD

    Child Psych ODD/CD/SUD

    49問 • 10ヶ月前
    Two Clean Queens

    問題一覧

  • 1

    Any swelling caused by inflammation

    Tumor

  • 2

    New, abnormal growth, following uncontrolled proliferation serving no physiological purpose

    Neoplasm

  • 3

    Slow growth, well-defined capsule, not invasive, well differentiated, no metastasis, low mitotic index

    Benign Tumor

  • 4

    Rapid growth, not encapsulated, invasive, poor differentiation (anaplasia), high mitotic index, can spread distally (metastasis)

    Malignant Tumor

  • 5

    Abnormal, uncontrolled, spread

    Cancer

  • 6

    -Constantly replace selves -Regenerate using adult stem cells -Stem cells are multi/pluripotent

    Normal cells

  • 7

    -Heterogeneous (diverse character/content) -Cancer stem cells

    Cancer Cells

  • 8

    Pre-invasive cancer; atypical cells. “In its original place”, cancer cells have not spread beyond where they were first formed, and have not penetrated the basement membrane (no local invasion)

    Carcinoma in situ

  • 9

    Tumors and other abnormal growths (morbid growth)

    -oma

  • 10

    Cancer from epithelial cells

    Carcinoma

  • 11

    Cancer from mesenchymal cells

    -sarcoma

  • 12

    Cancer from ductal or glandular tissue

    Adenocarcinoma

  • 13

    Cancer from blood forming cells

    Leukemia

  • 14

    Cancer from lymphatic cells

    Lymphoma

  • 15

    Cancer in precursor cells (blasts); common in children

    -blastoma

  • 16

    Mutated or over-expressed proto-oncogenes, which are independent of normal regulatory mechanisms. May amplify, making numerous copies of mutated genes that are important in prognosis and therapy.

    Oncogenes

  • 17

    Genes that inhibit or decelerate proliferation-> suppress oncogenes (decrease cell growth, mutation, replication)-> end result of gene changes = loss of caretaker gene function (TP53)

    Tumor suppressor gene role in cancer suppression

  • 18

    -Cancer cells use inflammation to their benefit to support growth and progression -Have ability to produce chemotactic signals -> attract macrophages-> produce mediators -> decrease inflammation and increase proliferation and angiogenesis, recruit macrophages, decrease cytotoxic response to not kill cancer cells -T-regulatory cells change -> no cell destruction + produce cytokines -> proliferation/spread

    Inflammation role in cancer progression

  • 19

    Muscle wasting, loss of lean body mass with or without adipose tissue, multi-organ syndrome, systemic inflammation, negative protein energy balance -Changes in mitochondrial Ca+ signaling, loss of myofibrils -Increased apoptosis and decrease regeneration -White adiopose tissue breakdown -> conversion to brown adipose tissue with increased thermogenesis (IL-6) -Changes in appetite hormones —>(Orexin < Anorexin levels)

    Cachexia

  • 20

    -(Rare) triggered by immune system response to neoplasm -Involves non-metastatic systematic effects that accompany malignant disease -Collection of symptoms produced by tumor occurring remotely from the tumor origin -Can effect neuromuscular, CV, cutaneous, hematologic, GI, renal, miscellaneous Examples - -SIADH <- intracranial neoplams -> release ADH -Venous thrombosis <- pancreatic carcinoma -> tumor products activate clotting

    Paraneoplastic Syndrome

  • 21

    It measures liver and germ cells

    Alpha Fetoprotein

  • 22

    It measures prostate cells

    PSA

  • 23

    It measures germ cell choriocarcinoma (for numerous cancers - colon, lung, and breast)

    Carcinoembryonic antigen

  • 24

    It measures urine marker for multiple myeloma

    Bence Jones Protein

  • 25

    It measures marker for small cell lung cancer and neuroblastoma

    Neuron-specific enolase

  • 26

    -The higher number the worse the prognosis - (T) indicates tumor spread - (N) indicates node involvement - (M) indicates presence of distal metastasis

    Process of staging cancers

  • 27

    Most common cancers - leukemia and brain tumor, solid tumors

    Cancer in Children

  • 28

    Lymphoma most common. Leukemia, thyroid carcinoma, brain tumors, and germ cell tumors are also common

    Cancer in Adolescents

  • 29

    Incidence increases with age, changes in immune system, immunocompetence, longer time exposed to potential gene mutations. More likely to develop solid organ tumor.

    Cancer in Elderly

  • 30

    Diagnosis during active growth periods, and approximately 85% are cured

    Cancer in Adolescents and Children

  • 31

    -Risk factors: smoking , COPD -Manifestations: non-productive cough, hemoptysis, PNA, atelectasis -Site of Metastasis: hila and project into bronchi

    Squamos cell carcinoma (lung)

  • 32

    -Risk factors: women, Asians, non-smokers -Manifestations: asymptomatic, and usually found on unrelated CXR -Site of metastasis: periphery of lung parenchyma

    Adenocarcinoma (lung)

  • 33

    -Risk factors: men > 60 yo, Asians -Manifestations: non-productive cough, hemoptysis, chest pain, PNA, SOB, orthopnea -Site of metastasis: central and distal trachea

    Large cell carcinoma (lung)

  • 34

    -Risk factors: smoking (strong relation) -Manifestations: Hyponatremia, Cushing’s, hypocalcemia, gyneomastia, carcinoid syndrome, Lambert-Eaton myasthenic syndrome -Pathophysiology: neuroendrocrine tumors derived from neuro-secretory granules in tracheobronchial trees -Site of metastasis: central portion of the lung

    Small cell carcinoma (lung)

  • 35

    -Risk factors: smoking, ETOH, low intake of fruit/vegetables, low zinc intake, hot food beverages -Manifestations: Chest pain and dysphagia -Pathophysiology: r/t chronic inflammation and metaplastic changes -Site of metastasis: upper portion of esophagus

    Squamous cell carcinoma (esophagus)

  • 36

    -Risk factors: Barrett’s esophagus, GERD, obesity, smoking, sliding hiatal hernia -Site of metastasis: lower esophagus

    Adenocarcinoma (esophagus)

  • 37

    -Risk factors: familial adenomatous polyposis, age 50+, black, family Hx, smoking, obesity, inactivity, high fat and low fiber diet, IBD, genetics, DMII -Etiology: arise from polyps in intestinal mucosal epithelium -Manifestations: if large enough-> bowel obstruction; pain abdominal mass, anemia, occult blood, distension -Pathophysiology: polyps with frequency in size

    Colon Cancer

  • 38

    -Risk factors: increase with age, ETOH, family Hx, non-O blood type, DMII, chronic pancreatitis, smoking, BRCA-2, Lynchburg and FAMMM Syndromes, K-ras (proto-oncogene) -Etiology: tumors arise from exocrine (more likely) and endocrine cells -Manifestations: obstruction of portal vein and common bile duct -> jaundice, dull black stool, protein and fat malabsorption, lethargy; weight loss, N/V, new onset DM, pruritis, light-colored or floating stools, dark urine, flank or back pain, abdominal pain, DVT

    Pancreatic cancer

  • 39

    -Risk factors: Family Hx, ovarian, breast, or uterine cancers, IVF, post-menopausal, infertility, early menarche, late menopause, endometriosis, BRCA1>BRCA2, Turners Syndrome -Etiology: unclear -Manifestations: vague, non-specific; Early -> decreased appetite, abdominal and pelvic pain, Late -> pain, ascities, dyspepsia, vomiting, change in bowel habits

    Ovarian cancer

  • 40

    -Risk factors: white > black (higher mortality), early menarche, late menopause, nulliparity, family Hx, personal Hx of breast or ovarian cancers, tamoxifen use, failure to ovulate, obesity, DMII, HTN, gallbladder disease -Etiology: prolonged estrogen exposure in absence of progesterone -Manifestations: post-menopausal bleeding, pain, weight loss (late sign), Metastasis -> lungs! -Pathophysiology: arises from glandular epithelial of the uterine lining (75% are Adenocarcinoma)

    Endometrial cancer

  • 41

    -Risk factors: early age at onset of sexual activity, multiple high risk partners, high risk HPV (strains 16 and 18), smoking, oral contraceptives, immunodeficiency -Etiology: HPV strains 16, 18 are higher risk; 6 & 11 are lower risk -Manifestations: no symptoms in early stage; large absent, may have post-coital vaginal bleeding, malodorous discharge, and abdominal uterine bleeding (late sign) -Pathophysiology: pre-cancerous dysplasia and cervical carcinoma in situ

    Cervical cancer

  • 42

    -Risk factors: early age (15-35 yo), white, Hx of undescended testicle, family Hx, HIV, Klinefelter Syndrome, genetics -Etiology: unknown -Manifestations: painless right testicular mass and heavinesses, dull ache in lower abdomen and lumbar, gynecomastia, CNS symptoms; Metastasis -> lung and brain! -Pathophysiology: malignant neoplasm of the testicle

    Testicular cancer

  • 43

    -Risk factors: age 50+, black, vasectomy, family Hx, high fat diet, smoking, obesity, ingestion of proinflammatory oils (corn and safflower oils), other tumor suppressors-> Genes BRCA2>BRCA1 -Etiology: unknown -Manifestations: not present until advanced stage - slow urinary stream, incomplete bladder emptying, low back pain, nocturia, dysuria, erectile dysfunction, increased alkaline phosphatase, rectal obstruction, pelvic pain; Metastasis-> vertebrae and pelvic bones! -Pathophysiology: imbalance of estrogen-androgen in epithelial cells

    Prostate cancer

  • 44

    -Risk factors: metabolic syndromes - dyslipidemia, insulin resistance, obesity, genetics, thyroid syndromes -Defining characteristics: irregular ovulation, increased androgen levels, polycystic ovaries -Manifestations: anovulation, hyperandrogenism, insulin dysfunction, bleeding/amenorrhea, hirsutism, acne, acanthosis nigricans, infertility -Pathophysiology: altered FSH results in failure of follicules to fully mature and alters ovulation

    Polycystic Ovarian Syndrome

  • 45

    -Risk factors: common during reproductive years in women -Defining characteristics: benign unilateral cysts

    Ovarian cysts

  • 46

    Follicle stimulated but does not mature, rupture, or regress. Symptoms- bloating, breast tenderness and swelling, heavy/irregular menses. Most are fluid-filled and reabsorpted with next “normal” hormone cycle

    Follicular cysts

  • 47

    Formed by granulosa cells “left behind” after ovulation (more prone to rupture) Symptoms-dull, unilateral pelvic pain, amenorrhea-> heavy irregular bleeding. Most regress spontaneously in non-pregnant women

    Corpus Luteum Cysts

  • 48

    Triggers a tissue-remodeling matrix -> makes new blood vessels for cancer cells

    Metalloproteinases

  • 49

    4 known genetic mechanisms of oncogenes

    1) point mutations 2) translocation with excess production of proliferation factor 3) translocation with production of proteins with growth-promoting properties 4) gene amplification

  • 50

    Sensitive but not specific

    AFP

  • 51

    Specific but not sensitive

    PSA

  • 52

    Metastasis-> vertebrae and pelvic bones!

    Prostate Cancer

  • 53

    Metastasis -> lung and brain!

    Testicular Cancer

  • 54

    Metastisis -> lungs!

    Endometrial Cancer